Coping After COVID: A Troubling Time for Schizophrenia Patients

Video

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

Episode highlights

0:22 Introduction
2:51 Short-Term Impacts of COVID-19
3:53 Long-Term Impacts of COVID-19
6:56 The Future of Telehealth
9:31 Limiting the Damage
11:43 Mistakes in Hindsight
15:49 Impulsive Behaviors
17:49 Younger Vs. Older Patients
20:09 Biggest Issues for Schizophrenia
22:11 Best Advice for Doctors and Patients

Schizophrenia can be difficult to treat, even in ideal settings.

But when the COVID-19 pandemic began to take shape, it became even tougher for this patient population.

Like most other psychiatric conditions, schizophrenia can be made worse by the added stress that comes along with a global pandemic.

And the disruption of a regular schedule with regular psychiatric health care appointments and treatment plans can be damaging.

In this month’s episode of Coping After COVID: Navigating Psychiatry After a Pandemic, Craig Chepke, MD, FAPA, Excel Psychiatric Associates, spoke about how difficult a time it could have been for schizophrenia patients.

Chepke said 1 of the more troubling aspects of the pandemic was that many patients neglected care. He said there has been a push over the course of the pandemic to address some of the mental health issues that are common under the circumstances, but he is worried that schizophrenia patients might specifically be falling through the cracks.

And outside of treatment and therapies, there are several initiatives that generally help schizophrenia patients, including socializing and job seeking. But that was also made difficult and unsafe during the course of the pandemic.

Related Videos
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Depression Screening: Challenges and Solutions at the Primary Care Level
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
© 2024 MJH Life Sciences

All rights reserved.